Orla Kjær-Christensen
Plus aucun poste en cours
Historique de carrière de Orla Kjær-Christensen
Anciens postes connus de Orla Kjær-Christensen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sparekassen Himmerland A/S
Sparekassen Himmerland A/S Regional BanksFinance Sparekassen Himmerland A/S is engaged in the provision of financial and banking services. It offers financial products and services to both private and corporate clients including pension, insurance, cash management, and investment management. The company was founded in December 14, 1871 and is headquartered in Aars, Denmark. | Sales & Marketing | - | 09/01/2014 |
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Directeur/Membre du Conseil | 01/01/2008 | - |
Directeur des opérations | 01/01/2008 | - |
Formation de Orla Kjær-Christensen
University of Tromso | Doctorate Degree |
Statistiques
Internationale
Norvège | 3 |
Danemark | 2 |
Opérationnelle
Sales & Marketing | 1 |
Director/Board Member | 1 |
Chief Operating Officer | 1 |
Sectorielle
Finance | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Sparekassen Himmerland A/S
Sparekassen Himmerland A/S Regional BanksFinance Sparekassen Himmerland A/S is engaged in the provision of financial and banking services. It offers financial products and services to both private and corporate clients including pension, insurance, cash management, and investment management. The company was founded in December 14, 1871 and is headquartered in Aars, Denmark. | Finance |
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
- Bourse
- Insiders
- Orla Kjær-Christensen
- Expérience